Allscripts adopts 'poison pill'; Banner awarded Stage 7;

> Electronic health record giant Allscripts has adopted a stockholder rights plan, also known as a "poison pill," to protect shareholders from a hostile takeover. Under the plan, the shareholders' repurchase rights are exercisable if a person or group without board approval acquires 10 percent or more of common stock or announces a tender offer that would result in the same. Article

> Phoenix-based Banner Health has been awarded Stage 7 attainment of EHR sophistication on the Electronic Medical Records Adoption Model (EMRAM) scale for 17 of its 23 hospitals, according to HIMSS Analytics. Only 66 U.S. hospitals have achieved Stage 7, the highest level available. Announcement

> EHRs will improve workflow and efficiencies, leading to improved patient outcomes, said Amit  Shanker, M.D. of Cooperstown, N.Y.-based Bassett Healthcare, speaking at the 33rd annual scientific sessions of the Heart Rhythm Society this week. "It will  be increasingly important for your practice to play where the puck is going to be," he pointed out. Article

And Finally... We're more like monkeys than we'd like to admit. Article

Suggested Articles

Roche, which already owned a 12.6% stake in Flatiron Health, has agreed to buy the health IT company for $1.9 billion.

Allscripts managed to acquire two EHR platforms for just $50 million by selling off a portion of McKesson's portfolio for as much as $235 million.

Artificial intelligence could help physicians predict a patient's risk of developing a deadly infection.